D-Limonene: A bioactive food component from citrus and evidence for a potential role in breast cancer prevention and treatment

Oncology Reviews

Volumn 5, Issue 1, 2011, Pages 31-42

  Miller, Jessica A ^a   Thompson, Patricia A ^b   Hakim, Iman A ^a,b   Chow, H H Sherry ^b   Thomson, Cynthia A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Bioactive food component; Breast cancer; d Limonene; Perillyl alcohol

Indexed keywords

ANTINEOPLASTIC AGENT; CITRUS FRUIT EXTRACT; LIMONENE; PERILLYL ALCOHOL; PROTEIN FARNESYLTRANSFERASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOPROPHYLAXIS; CITRUS FRUIT; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW;

EID: 79954575341     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-010-0066-8     Document Type: Review

References (77)

1. National Institutes of Health 2008. http://dietary-supplements.info.nih. gov/Research/Bioactive-Food-Components-Initiatives.aspx
2. YS Kim MR Young G Bobe NH Colburn JA Milner 2009 Bioactive food components, inflammatory targets, and cancer prevention Cancer Prev Res 2 200 208 10.1158/1940-6207.CAPR-08-0141 1:CAS:528:DC%2BC3cXptVykurw%3D
3. KH Wagner I Elmadfa 2003 Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes Ann Nutr Metab 47 95 106 12743459 10.1159/000070030 1:CAS:528:DC%2BD3sXjslanurs%3D (Pubitemid 36578799)
4. T Rabi A Bishayee 2009 Terpenoids and breast cancer chemoprevention Breast Cancer Res Treat 115 223 239 18636327 10.1007/s10549-008-0118-y 1:CAS:528:DC%2BD1MXmsVGjsrc%3D
5. MN Gould 1997 Cancer chemoprevention and therapy by monoterpenes Environ Health Perspect 105 Suppl 4 977 979 9255590 10.2307/3433313 1:CAS:528: DyaK2sXls1elsLs%3D (Pubitemid 27372991)
6. J Sun 2007 d-Limonene: safety and clinical applications Altern Med Rev 12 259 264 18072821 (Pubitemid 47613223)
7. HS Choi 2006 Lipolytic effects of citrus peel oils and their components J Agric Food Chem 54 3254 3258 16637681 10.1021/jf052409j 1:CAS:528: DC%2BD28Xjt1Kmsbg%3D (Pubitemid 43798193)
8. S Del Toro-Arreola E Flores-Torales C Torres-Lozano A Del Toro-Arreola K Tostado-Pelayo M Guadalupe Ramirez-Duenas A Daneri-Navarro 2005 Effect of d-limonene on immune response in BALB/c mice with lymphoma Int Immunopharmacol 5 829 838 15778119 10.1016/j.intimp.2004.12.012 1:CAS:528:DC%2BD2MXitlOgtrk%3D (Pubitemid 40381117)
9. TH Maltzman LM Hurt CE Elson MA Tanner MN Gould 1989 The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil Carcinogenesis 10 781 783 2702727 10.1093/carcin/10.4.781 1:CAS:528: DyaL1MXitVGhsb8%3D (Pubitemid 19101303)
10. CE Elson TH Maltzman JL Boston MA Tanner MN Gould 1988 Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis Carcinogenesis 9 331 332 3123086 10.1093/carcin/9.2.331 1:CAS:528:DyaL1cXktlOitr8%3D (Pubitemid 18038001)
11. MN Gould CJ Moore R Zhang B Wang WS Kennan JD Haag 1994 Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras Cancer Res 54 3540 3543 8012978 1:CAS:528:DyaK2cXkslehsbw%3D
12. PL Crowell MN Gould 1994 Chemoprevention and therapy of cancer by d-limonene Crit Rev Oncog 5 1 22 7948106 1:CAS:528:DyaK2cXmsVCksbY%3D (Pubitemid 2125282)
13. XG Lu LB Zhan BA Feng MY Qu LH Yu JH Xie 2004 Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene World J Gastroenterol 10 2140 2144 15237454 1:CAS:528:DC%2BD2cXmslKitLc%3D
14. N Uedo M Tatsuta H Iishi M Baba N Sakai H Yano T Otani 1999 Inhibition by d-limonene of gastric carcinogenesis induced by N-methyl-N′-nitro-N- nitrosoguanidine in Wistar rats Cancer Lett 137 131 136 10374833 10.1016/S0304-3835(98)00340-1 1:CAS:528:DyaK1MXitlGqu7c%3D (Pubitemid 29179455)
15. I Kaji M Tatsuta H Iishi M Baba A Inoue H Kasugai 2001 Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association Int J Cancer 93 441 444 11433412 10.1002/ijc.1353 1:CAS:528:DC%2BD3MXlt12gsbc%3D (Pubitemid 32592066)
16. RK Giri T Parija BR Das 1999 d-Limonene chemoprevention of hepatocarcinogenesis in AKR mice: inhibition of c-jun and c-myc Oncol Rep 6 1123 1127 10425313 1:CAS:528:DyaK1MXlsFegsbY%3D
17. TJ Raphael G Kuttan 2003 Effect of naturally occurring monoterpenes carvone, limonene and perillic acid in the inhibition of experimental lung metastasis induced by B16F-10 melanoma cells J Exp Clin Cancer Res 22 419 424 14582701 1:CAS:528:DC%2BD3sXpt1Grtb4%3D (Pubitemid 37205399)
18. T Rabi A Bishayee 2009 d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: generation of reactive oxygen species and induction of apoptosis J Carcinog 8 9 19465777 10.4103/1477-3163. 51368
19. Carey LA (2010) Through a glass darkly: advances in understanding breast cancer biology, 2000-2010. Clin Breast Cancer 10:188-195
20. PL Crowell CE Elson HH Bailey A Elegbede JD Haag MN Gould 1994 Human metabolism of the experimental cancer therapeutic agent d-limonene Cancer Chemother Pharmacol 35 31 37 7987974 10.1007/BF00686281 1:CAS:528: DyaK2MXltlGrs7c%3D (Pubitemid 24356744)
21. DM Vigushin GK Poon A Boddy J English GW Halbert C Pagonis M Jarman RC Coombes 1998 Phase I and pharmacokinetic study of d-limonene in patients with advanced cancer Cancer Research Campaign Phase I/II Clinical Trials Committee Cancer Chemother Pharmacol 42 111 117 9654110 10.1007/s002800050793 1:CAS:528:DyaK1cXjslWmurw%3D (Pubitemid 28267291)
22. GK Poon D Vigushin LJ Griggs MG Rowlands RC Coombes M Jarman 1996 Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometry Drug Metab Dispos 24 565 571 8723738 1:CAS:528:DyaK28XivVOnu7s%3D (Pubitemid 26146701)
23. S Bardon K Picard P Martel 1998 Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines Nutr Cancer 32 1 7 9824849 10.1080/01635589809514708 1:CAS:528: DyaK1cXnslSqur4%3D (Pubitemid 28519235)
24. JD Haag MN Gould 1994 Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene Cancer Chemother Pharmacol 34 477 483 7923558 10.1007/BF00685658 1:CAS:528:DyaK2MXis1Onu7k%3D (Pubitemid 24306046)
25. Z Ren CE Elson MN Gould 1997 Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells Biochem Pharmacol 54 113 120 9296357 10.1016/S0006-2952(97)00151-2 1:CAS:528:DyaK2sXlsVGqu74%3D (Pubitemid 27353228)
26. H Loutrari M Hatziapostolou V Skouridou E Papadimitriou C Roussos FN Kolisis A Papapetropoulos 2004 Perillyl alcohol is an angiogenesis inhibitor J Pharmacol Exp Ther 311 568 575 15210838 10.1124/jpet.104.070516 1:CAS:528:DC%2BD2cXptVKrtb8%3D (Pubitemid 39391541)
27. RL Jirtle JD Haag EA Ariazi MN Gould 1993 Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors Cancer Res 53 3849 3852 8358708 1:CAS:528:DyaK2cXhvVw%3D (Pubitemid 23267674)
28. HH Bailey S Attia RR Love T Fass R Chappell K Tutsch L Harris A Jumonville R Hansen GR Shapiro JA Stewart 2008 Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer Cancer Chemother Pharmacol 62 149 157 17885756 10.1007/s00280-007-0585-6 1:CAS:528:DC%2BD1cXks1KrsL4%3D (Pubitemid 351537855)
29. CG Azzoli VA Miller KK Ng LM Krug DR Spriggs WP Tong ER Riedel MG Kris 2003 A phase I trial of perillyl alcohol in patients with advanced solid tumors Cancer Chemother Pharmacol 51 493 498 12695855 1:CAS:528:DC%2BD3sXksFWmsL8%3D (Pubitemid 36791675)
30. GR Hudes CE Szarka A Adams S Ranganathan RA McCauley LM Weiner CJ Langer S Litwin G Yeslow T Halberr M Qian JM Gallo 2000 Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies Clin Cancer Res 6 3071 3080 10955786 1:CAS:528:DC%2BD3cXmsVOmsbg%3D (Pubitemid 30637730)
31. Miller JA, Hakim IA, Chew W, Thompson P, Thomson CA, Chow SH-H (2010) Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content. Nutr Cancer 62(6):783-788
32. DG DeNardo LM Coussens 2007 Inflammation and breast cancer balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression Breast Cancer Res 9 212 17705880 10.1186/bcr1746
33. G Curigliano M Rescigno A Goldhirsch 2007 Immunology and breast cancer: therapeutic cancer vaccines Breast 16 Suppl 2 S20 S26 17706425 10.1016/j.breast.2007.07.004 (Pubitemid 350028551)
34. DL Evans DM Miller KL Jacobsen PB Bush 1987 Modulation of immune responses in mice by d-limonene J Toxicol Environ Health 20 51 66 3492608 10.1080/15287398709530961 1:CAS:528:DyaL2sXhtlOit7g%3D (Pubitemid 17013629)
35. M Hamada K Uezu J Matsushita S Yamamoto Y Kishino 2002 Distribution and immune responses resulting from oral administration of d-limonene in rats J Nutr Sci Vitaminol 48 155 160 12171437 1:CAS:528:DC%2BD38XktlGjtLg%3D (Pubitemid 34733448)
36. TJ Raphael G Kuttan 2003 Immunomodulatory activity of naturally occurring monoterpenes carvone, limonene, and perillic acid Immunopharmacol Immunotoxicol 25 285 294 12784919 10.1081/IPH-120020476 1:CAS:528:DC%2BD3sXkslKrt7w%3D (Pubitemid 36597423)
37. LA Emens 2008 Cancer vaccines: on the threshold of success Expert Opin Emerg Drugs 13 295 308 18537522 10.1517/14728214.13.2.295 1:CAS:528: DC%2BD1cXmvVCktLk%3D (Pubitemid 351957349)
38. E Giarelli 2007 Cancer vaccines: a new frontier in prevention and treatment Oncology 21 11 17 18154203 discussion 18
39. RG Mehta RC Moon 1991 Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol Anticancer Res 11 593 596 1905902 1:CAS:528:DyaK3MXlt1KmtrY%3D
40. J Hoffmann R Bohlmann N Heinrich H Hofmeister J Kroll H Kunzer RB Lichtner Y Nishino K Parczyk G Sauer H Gieschen HF Ulbrich MR Schneider 2004 Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer J Natl Cancer Inst 96 210 218 14759988 10.1093/jnci/djh022 1:CAS:528:DC%2BD2cXhtVKkurs%3D (Pubitemid 38263180)
41. HJ Thompson M Singh 2000 Rat models of premalignant breast disease J Mammary Gland Biol Neoplasia 5 409 420 14973385 10.1023/A:1009582012493 1:STN:280:DC%2BD2c%2FosFWrtg%3D%3D (Pubitemid 32236771)
42. H Szaefer V Krajka-Kuzniak W Baer-Dubowska 2008 The effect of initiating doses of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene on the expression of PAH activating enzymes and its modulation by plant phenols Toxicology 251 28 34 18694800 10.1016/j.tox.2008.07.047 1:CAS:528:DC%2BD1cXhtV2jtrjF
43. AC De-Oliveira LF Ribeiro-Pinto JR Paumgartten 1997 In vitro inhibition of CYP2B1 monooxygenase by beta-myrcene and other monoterpenoid compounds Toxicol Lett 92 39 46 9242356 10.1016/S0378-4274(97)00034-9 1:CAS:528: DyaK2sXkvFanu7k%3D (Pubitemid 27289494)
44. Pervin S, Chaudhuri G, Singh R (2010) NO to breast: when, why and why not? Curr Pharm Des 16:451-462
45. A Murakami Y Nakamura Y Ohto M Yano T Koshiba K Koshimizu H Tokuda H Nishino H Ohigashi 2000 Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid Biofactors 12 187 192 11216485 10.1002/biof.5520120130 1:CAS:528:DC%2BD3MXhsFegu7o%3D (Pubitemid 32107406)
46. C Gerhauser K Klimo E Heiss I Neumann A Gamal-Eldeen J Knauft GY Liu S Sitthimonchai N Frank 2003 Mechanism-based in vitro screening of potential cancer chemopreventive agents Mutat Res 523-524 163 172 12628514 (Pubitemid 36293243)
47. Roberto D, Micucci P, Sebastian T, Graciela F, Anesini C (2009) Antioxidant activity of limonene on normal murine lymphocytes: relation to HO modulation and cell proliferation. Basic Clin Pharmacol Toxicol 106:38-44
48. MH Gelb F Tamanoi K Yokoyama F Ghomashchi K Esson MN Gould 1995 The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol Cancer Lett 91 169 175 7767906 10.1016/0304-3835(95)03747-K 1:CAS:528:DyaK2MXlvVSqs70%3D
49. PL Crowell RR Chang ZB Ren CE Elson MN Gould 1991 Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites J Biol Chem 266 17679 17685 1894647 1:CAS:528:DyaK3MXltVGlsL8%3D (Pubitemid 21907991)
50. JA McCubrey LS Steelman WH Chappell SL Abrams EW Wong F Chang B Lehmann DM Terrian M Milella A Tafuri F Stivala M Libra J Basecke C Evangelisti AM Martelli RA Franklin 2007 Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance Biochim Biophys Acta 1773 1263 1284 17126425 10.1016/j.bbamcr.2006.10.001 1:CAS:528:DC%2BD2sXosFyksbk%3D (Pubitemid 47125967)
51. TB Brunner SM Hahn WG McKenna EJ Bernhard 2004 Radiation sensitization by inhibition of activated Ras Strahlenther Onkol 180 731 740 15549191 10.1007/s00066-004-9198-8 (Pubitemid 40022280)
52. H Mo CE Elson 2004 Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention Exp Biol Med 229 567 585 1:CAS:528:DC%2BD2cXlslWqsL8%3D (Pubitemid 38878903)
53. NM Appels JH Beijnen JH Schellens 2005 Development of farnesyl transferase inhibitors: a review Oncologist 10 565 578 16177281 10.1634/theoncologist.10-8-565 (Pubitemid 41429120)
54. JL Bos 1989 Ras oncogenes in human cancer: a review Cancer Res 49 4682 4689 2547513 1:CAS:528:DyaL1MXltlWksL4%3D (Pubitemid 19213607)
55. RM O'Regan FR Khuri 2004 Farnesyl transferase inhibitors: the next targeted therapies for breast cancer? Endocr Relat Cancer 11 191 205 15163298 10.1677/erc.0.0110191 (Pubitemid 38842410)
56. JD Haag MJ Lindstrom MN Gould 1992 Limonene-induced regression of mammary carcinomas Cancer Res 52 4021 4026 1617679 1:CAS:528:DyaK38Xks1amsLo%3D
57. SK Chander AG Lansdown YA Luqmani JJ Gomm RC Coope N Gould RC Coombes 1994 Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumours Br J Cancer 69 879 882 8180018 10.1038/bjc.1994.170 1:CAS:528:DyaK2cXls12ru78%3D (Pubitemid 24140668)
58. D Padua J Massague 2009 Roles of TGFbeta in metastasis Cell Res 19 89 102 19050696 10.1038/cr.2008.316 1:CAS:528:DC%2BD1MXht1GgsA%3D%3D
59. Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE (2010) Targeting fibroblast growth factor receptors blocks PI3 K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis. Cancer Res 70:4151-4162
60. Hsieh CC, Hernandez-Ledesma B, de Lumen BO (2010) Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis. Chem Biol Interact 186:127-134
61. JA Miller IA Hakim C Thomson P Thompson HH Chow 2008 Determination of d-limonene in adipose tissue by gas chromatography-mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 870 68 73 18571481 10.1016/j.jchromb.2008.06.002 1:CAS:528:DC%2BD1cXotlOjsbk%3D
62. T Liu Y Guo Z Gao Z Chen X Jiang 2008 Bioequivalence evaluation of two d-limonene capsule formulations in healthy Chinese volunteers Pharmazie 63 718 720 18972832 1:CAS:528:DC%2BD1cXht1GmsbvF
63. H Chen KK Chan T Budd 1998 Pharmacokinetics of d-limonene in the rat by GC-MS assay J Pharm Biomed Anal 17 631 640 9682146 10.1016/S0731-7085(97)00243-4 1:CAS:528:DyaK1cXkvFWhsb4%3D (Pubitemid 28302688)
64. PL Crowell WS Kennan JD Haag S Ahmad E Vedejs MN Gould 1992 Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene Carcinogenesis 13 1261 1264 1638695 10.1093/carcin/13.7.1261 1:CAS:528:DyaK38Xls1egt7c%3D
65. EA McSherry S Donatello AM Hopkins S McDonnell 2007 Molecular basis of invasion in breast cancer Cell Mol Life Sci 64 3201 3218 17957337 10.1007/s00018-007-7388-0 1:CAS:528:DC%2BD1cXmtVyltA%3D%3D
66. IA Hakim RB Harris C Ritenbaugh 2000 Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin Nutr Cancer 37 161 168 11142088 10.1207/S15327914NC372-7 1:STN:280:DC%2BD3Mrks1Chsw%3D%3D
67. IA Hakim RB Harris 2001 Joint effects of citrus peel use and black tea intake on the risk of squamous cell carcinoma of the skin BMC Dermatol 1 3 11527506 10.1186/1471-5945-1-3 1:STN:280:DC%2BD3srgs1Whsg%3D%3D (Pubitemid 38750943)
68. BN Fink SE Steck MS Wolff GC Kabat MD Gammon 2006 Construction of a flavonoid database for assessing intake in a population-based sample of women on Long Island, New York Nutr Cancer 56 57 66 17176218 10.1207/s15327914nc5601-8 1:CAS:528:DC%2BD2sXhvVOmsLY%3D (Pubitemid 46173414)
69. SA Smith-Warner D Spiegelman SS Yaun HO Adami WL Beeson PA van den Brandt AR Folsom GE Fraser JL Freudenheim RA Goldbohm S Graham AB Miller JD Potter TE Rohan FE Speizer P Toniolo WC Willett A Wolk A Zeleniuch-Jacquotte DJ Hunter 2001 Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies JAMA 285 769 776 11176915 10.1001/jama.285.6.769 1:STN:280:DC%2BD3M7ltVOmtA%3D%3D (Pubitemid 32167236)
70. AJ McEligot J Largent A Ziogas D Peel H Anton-Culver 2006 Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer Nutr Cancer 55 132 140 17044767 10.1207/s15327914nc5502-3 1:CAS:528:DC%2BD28XhtlentLvJ (Pubitemid 44719626)
71. CA Taylor JS Hampl CS Johnston 2000 Low intakes of vegetables and fruits, especially citrus fruits, lead to inadequate vitamin C intakes among adults Eur J Clin Nutr 54 573 578 10918468 10.1038/sj.ejcn.1601059 1:STN:280: DC%2BD3M%2FpsFWrtQ%3D%3D (Pubitemid 30447325)
72. CA Gonzalez G Pera A Agudo HB Bueno-de-Mesquita M Ceroti H Boeing M Schulz G Del Giudice M Plebani F Carneiro F Berrino C Sacerdote R Tumino S Panico G Berglund H Siman G Hallmans R Stenling C Martinez M Dorronsoro A Barricarte C Navarro JR Quiros N Allen TJ Key S Bingham NE Day J Linseisen G Nagel K Overvad MK Jensen A Olsen A Tjonneland FL Buchner PH Peeters ME Numans F Clavel-Chapelon MC Boutron-Ruault D Roukos A Trichopoulou T Psaltopoulou E Lund C Casagrande N Slimani M Jenab E Riboli 2006 Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) Int J Cancer 118 2559 2566 16380980 10.1002/ijc.21678 1:CAS:528:DC%2BD28XktlGhsr8%3D
73. AS Malin D Qi XO Shu YT Gao JM Friedmann F Jin W Zheng 2003 Intake of fruits, vegetables and selected micronutrients in relation to the risk of breast cancer Int J Cancer 105 413 418 12704679 10.1002/ijc.11088 1:CAS:528: DC%2BD3sXktlWitrc%3D (Pubitemid 36570057)
74. A Trichopoulou T Costacou C Bamia D Trichopoulos 2003 Adherence to a Mediterranean diet and survival in a Greek population N Engl J Med 348 2599 2608 12826634 10.1056/NEJMoa025039 (Pubitemid 36741587)
75. S Gallus C Bosetti C La Vecchia 2004 Mediterranean diet and cancer risk Eur J Cancer Prev 13 447 452 15452458 10.1097/00008469-200410000-00013 1:STN:280:DC%2BD2crjt1eqtw%3D%3D (Pubitemid 39336610)
76. IAMT Hakim D Liebler 2000 Assessing dietary d-limonene intake for epidemiological studies J Food Compos Anal 13 329 336 10.1006/jfca.1999.0862 1:CAS:528:DC%2BD3cXntVWnsr4%3D
77. AF El-Kattan CS Asbill N Kim BB Michniak 2001 The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities Int J Pharm 215 229 240 11250108 10.1016/S0378-5173(00)00699-2 1:CAS:528:DC%2BD3MXhslelurg%3D (Pubitemid 32206620)